5,0
30 ott 2018
Dipendente anonimo
Dipendente attuale
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
A leading independent healthcare M&A advisory firm with a major up and coming middle market presence
Svantaggi
Deals are hard and the work is demanding